Edgardo Santos MD FACP, FASCO
Thoracic Cancer
The Oncology Institute of Hope and Innovation Medical Director- Broward County, FL Medical Oncology- Thoracic Clinical Associate Professor, Charles E. Schmidt College of Medicine, Florida Atlantic University Vice-President, Florida Society of Clinical Oncology (FLASCO); President, FLASCO Foundation
Join to view full profile
500 SE 17th Street, Suite 100Fort Lauderdale, FL 33316
Phone+1 754-336-3426
Fax+1 754-241-4659
Dr. Santos is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Edgardo S. Santos is an oncologist in Fort Lauderdale with an expertise in lung cancer. He is affiliated with Aventura Hospital and Delray Medical Center. He received his medical degree from Universidad de Panama School of Medicine in 1994. He specializes in lung cancer & head & neck cancer. He is a member of ASCO, ASH, ESMO, AACR, ISLB, IASLC, ACP and OLA. He is the Medical Director of Broward County, FL for The Oncology Institute of Hope and Innovation.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2001 - 2004- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1998 - 2001
Universidad de Panama Faculty of MedicineClass of 1994
Certifications & Licensure
FL State Medical License 2001 - 2028
LA State Medical License 2004 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2014-2017
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2014-2017
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2014-2017
Clinical Trials
- A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
Publications & Presentations
PubMed
- Extending the clinical indications of liquid biopsy: plasma next-generation sequencing in suspected lung cancer.Alessandro Russo, Christian Rolfo, Edgardo S Santos
Translational Lung Cancer Research. 2025-08-31 - CGE25-111: Enhancing Oncology Treatment Personalization through Plasma Proteomics and Machine Learning.Kimberly McGregor, Michal Harel, Adam P Dicker, Janakiraman Subramanian, Edgardo S Santos
Journal of the National Comprehensive Cancer Network. 2025-03-28 - 2 citationsImpact of PROphet Test in Changing Physicians' Therapeutic Decision-Making for Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer.David R Gandara, Janakiraman Subramanian, Edgardo S Santos, Yehuda Brody, Itamar Sela
Clinical Lung Cancer. 2024-09-01
Press Mentions
The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo SantosSeptember 2nd, 2025- The Role of the Multidisciplinary Team for ROS1+ NSCLCFebruary 1st, 2025
- Revolutionizing Lung Cancer Care: The Impact of Liquid BiopsiesJanuary 1st, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
